Telehealth Revenue Growth
Telehealth revenue increased by 18% year-over-year to $47.3 million with telehealth adjusted EBITDA growing 30%.
RexMD Subscriber Growth
RexMD business added approximately 10,000 net new subscribers, signaling a return to growth.
Regulatory Approval for Pharmacy
LifeMD secured regulatory approval for its nonsterile 503-A compounding pharmacy, which will expand the ability to produce personalized medications at scale.
Partnerships with Pharmaceutical Companies
Collaborations with Novo Nordisk and Eli Lilly to offer branded weight management therapies at reduced prices.
Strong Balance Sheet
LifeMD reported the strongest balance sheet and liquidity position in the company's history, with $23.8 million in cash and no debt.